The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

IELSG36

( NCT02853370 )

IELSG36

( NCT02853370 )

Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma
| |

All Trials